|
|
Volumn 174, Issue 12, 2001, Pages 617-618
|
|
Non-multiresistant methicillin-resistant Staphylococcus aureus in the community: Next chapter in the story of staphylococcal sepsis?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
ANTIBIOTIC AGENT;
CHLORAMPHENICOL;
CIPROFLOXACIN;
CLINDAMYCIN;
COTRIMOXAZOLE;
DALFOPRISTIN PLUS QUINUPRISTIN;
DICLOXACILLIN;
ERYTHROMYCIN;
FLUCLOXACILLIN;
FUSIDATE SODIUM;
GENTAMICIN;
LINEZOLID;
METICILLIN;
OXAZOLIDINONE DERIVATIVE;
PENICILLIN G;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RIFAMPICIN;
SULFONAMIDE;
TETRACYCLINE;
TRIMETHOPRIM;
VANCOMYCIN;
ANTIBIOTIC SENSITIVITY;
AUSTRALIA;
BACTERIUM IDENTIFICATION;
BACTERIUM ISOLATE;
COMMUNICABLE DISEASE;
DRUG COST;
DRUG SCREENING;
EDITORIAL;
ENDEMIC DISEASE;
EPIDEMIC;
GENETIC ANALYSIS;
GENOTYPE;
HEALTH CARE COST;
HOSPITAL INFECTION;
HUMAN;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MULTIDRUG RESISTANCE;
NONHUMAN;
PHENOTYPE;
PRACTICE GUIDELINE;
PREVALENCE;
SEPSIS;
TEACHING HOSPITAL;
TREATMENT INDICATION;
TREATMENT PLANNING;
|
|
EID: 0035907604
PISSN: 0025729X
EISSN: None
Source Type: Journal
DOI: 10.5694/j.1326-5377.2001.tb143467.x Document Type: Editorial |
|
Times cited : (10)
|
|
References (16)
|
